SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (429)4/1/2003 1:50:24 AM
From: scaram(o)uche  Read Replies (1) of 469
 
Celltech face plants! Yahoo!

Unfortunately, they're going to profit. But let's do what we can do hold the jerks to the very minimum, and to make Fellner spend as much cash as possible to get it.............

Celltech: 3.86% Oxford GlycoSciences Accept offer
Tuesday April 1, 1:26 am ET

Edited Press Release
LONDON -(Dow Jones)- Celltech said Tuesday that by 1500 GMT on March 31, acceptances of the offer had been received in respect of 2,161,947 Oxford Glycosciences (OGS) shares (including those represented by OGS ADSs), representing 3.86% of the issued share capital of OGS.

In addition, as previously announced, on March 24 Celltech purchased 5,892,971 OGS shares (10.52%) at 182 pence per share. Celltech did not hold any OGS shares prior to the commencement of the offer period.

Accordingly an aggregate of 8,054,918 OGS shares (14.38%) have been acquired by Celltech or have been validly assented to the offer.

Celltech said it has therefore decided to extend the offer until 1400 GMT on April 15.

The Board of Celltech continues to believe that its all cash offer of 182 pence is generous and encourages OGS securityholders to accept its offer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext